- Home
- SRTS vs PAVM Comparison
SRTS vs PAVM Comparison
Compare SRTS & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRTS | PAVM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | 60 | 41 |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 52.1M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRTS | PAVM |
|---|---|---|
| Price | $3.19 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $7.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 72.2K | 13.8K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,482,000.00 | N/A |
| Revenue This Year | $2.00 | $603.94 |
| Revenue Next Year | $34.23 | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.82 | $0.21 |
| 52 Week High | $5.92 | $28.44 |
Technical Indicators
Market Signals| Indicator | SRTS | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 34.11 |
| Support Level | $3.03 | $6.11 |
| Resistance Level | $3.53 | $10.98 |
| Average True Range (ATR) | 0.26 | 0.40 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 23.97 | 18.07 |
Price Performance
Historical ComparisonAbout SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.